Incidence and predictors of mortality after an electrical storm in the ICU.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
14 Jun 2022
Historique:
received: 28 02 2022
revised: 05 04 2022
accepted: 05 04 2022
pubmed: 6 5 2022
medline: 18 6 2022
entrez: 5 5 2022
Statut: ppublish

Résumé

For assessing predictors of early mortality following hospitalization for electrical storm (ES), only limited data are available. The purpose of this study was to assess the incidence and predictors of early mortality following hospitalization in the intensive care unit (ICU) for ES in a large retrospective study. In this retrospective study, we included all patients who were hospitalized for ES from July 2015 to May 2020 in our tertiary centre. A total of 253 patients were included. The median age was 66 [56; 73], and 64% had ischemic cardiomyopathy. A total of 37% of patients presented hemodynamic instability requiring catecholamine at admission. A total of 17% of patients presented an acute reversible cause for ES. The one-year mortality was 34% (95% CI, 30-43%), mostly driven by heart failure (HF). The multivariable Cox's regression model identified age, left ventricular ejection fraction, right ventricle dysfunction, haemoglobin level as independent predictors of one-year mortality. The use of catecholamine at admission was identified as the only variable related to the initial management of ES associated with an increased 30-day mortality risk (HR: 7.95 (95%CI, 3.18-19.85). In patients admitted for ES in ICU, the one-year mortality remains high and mostly driven by HF. The use of catecholamine at admission is associated with a seven-fold risk for mortality within 30 days. In such patients, the potential use of VT ablation can be questioned and a careful action plan regarding invasive HF-related therapy could be considered.

Identifiants

pubmed: 35512138
pii: 6580071
doi: 10.1093/ehjacc/zuac044
doi:

Substances chimiques

Catecholamines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-439

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Sandro Ninni (S)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

Jeremy Layec (J)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

François Brigadeau (F)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

Hélène Behal (H)

Univ. Lille, CHU Lille, ULR 2694-METRICS: évaluation des technologies de santé et des pratiques médicales, F59000 Lille, France.

Julien Labreuche (J)

Univ. Lille, CHU Lille, ULR 2694-METRICS: évaluation des technologies de santé et des pratiques médicales, F59000 Lille, France.

Cédric Klein (C)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

Guillaume Schurtz (G)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

Charlotte Potelle (C)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

Augustin Coisne (A)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

Gilles Lemesle (G)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

Nicolas Lamblin (N)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

Didier Klug (D)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

Dominique Lacroix (D)

CHU Lille, Institut Coeur-Poumon, service de cardiologie, F-59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH